22157.jpg
Global Carboxy Therapy Market Forecast Report to 2028 - Compound Annual Growth of 12.25% Forecast During 2023-2028
December 22, 2023 04:33 ET | Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Carboxy Therapy Market: Analysis and Trends by Type, Application, End User and Region and Forecast up to 2028" report has been added to ...
PhysicianLogo.jpg
Physician Growth Partners advises Advanced Dermatology in partnership with Forefront Dermatology
December 20, 2023 09:21 ET | Physician Growth Partners
CHICAGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Physician Growth Partners (“PGP”) is pleased to have advised Advanced Dermatology (“Advanced Derm”), a sixteen-provider medical and cosmetic dermatology...
AIVAVA BIOPHARMA COLOR.png
AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
December 11, 2023 08:00 ET | AiViva Biopharma
Novel Non-surgical Intradermal Treatment for Basel Cell Carcinoma COSA MESA, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced...
BMS Attributes Sotyk
BMS Attributes Sotyktu Falling Short of Growth Expectations to Access, but Recent Spherix Global Insights’ Data Suggest Safety Concerns Are More of a Barrier to Increased Uptake
December 07, 2023 12:01 ET | Spherix Global Insights
Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- While access took the forefront of BMS’ response to Sotyktu (deucravacitinib) not meeting growth expectations during the company’s Q3 earnings call,...
journeylogo (1).jpg
Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea
December 06, 2023 08:00 ET | Journey Medical Corporation
SCOTTSDALE, Ariz., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses...
Straits Research Pvt Ltd
Global Anti-Acne Cosmetics Market Size is Estimated to Reach USD 8460 million by 2030, Growing at a CAGR of 9.3%: Straits Research
December 04, 2023 13:50 ET | Straits Research
New York, United States, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Acne vulgaris is a prevalent skin disorder that affects around 85 percent of the world's population (aged 11 to 30). The significant...
Vantage Market Research.png
With 11.40% CAGR, Dermatology Devices Market Size Worth $31.72 Billion by 2030 | Vantage Market Research
November 28, 2023 10:15 ET | Vantage Market Research
WASHINGTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Dermatology Devices Market achieved a valuation of $13.37 Billion in 2022 and is anticipated to exceed $31.72 Billion by 2030, reflecting a...
From left: Drs. Bertucci and Matarasso
Seth L. Matarasso, MD, Begins ASDS / ASDSA Presidency
November 27, 2023 12:45 ET | American Society for Dermatologic Surgery
Schaumburg, Ill., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Esteemed dermatologic surgeon Seth L. Matarasso, MD, began his one-year presidential term for the American Society for Dermatologic Surgery (ASDS)...
Global Dermatology Devices Market
Global Dermatology Devices Market Analysis & Forecast to 2023-2033: Increasing Product Approvals by U.S. FDA is Forecast to Boost Market Growth
November 16, 2023 10:53 ET | Research and Markets
Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The "Global Dermatology Devices Market Analysis & Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global...
Eli Lilly's Olumiant
Eli Lilly's Olumiant and Pfizer's Litfulo Strengthen Alopecia Areata Arsenal, Yet Resounding Opportunity for JAK Expansion and New Assets in Development Remain
November 15, 2023 11:22 ET | Spherix Global Insights
Exton, Pennsylvania, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Spherix Global Insights has been monitoring the alopecia areata (AA) market for the past four years and has found that the entry of JAK...